TP53 and breast carcinoma: Using targeted Sanger sequencing and Pyrosequencing, Jiang et al.28 reported that the allele frequencies of p53 and PIK3CA mutations tended to fall in breast cancers after they responded to taxol and carboplatin, but the study did not perform deep sequencing or examine tumour purity changes.